...
首页> 外文期刊>World journal of gastroenterology : >Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
【24h】

Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.

机译:体外商陆抗病毒蛋白抑制乙型肝炎病毒复制。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To explore the inhibitory effects of pokeweed antiviral protein seed (PAP-S) and PAP encoded by a eukaryotic expression plasmid on hepatitis B virus (HBV) replication in vitro. METHODS: HepG2 2.2.15 cells in cultured medium were treated with different concentrations of PAP-S. HBsAg, HBeAg and HBV DNA in supernatants were determined by ELISA and fluorescent quantitative PCR respectively. MTT method was used to assay for cytotoxicity. HepG2 were cotransfected with various amounts of PAP encoded by a eukaryotic expression plasmid and replication competent wild-type HBV 1.3 fold over-length plasmid. On d 3 after transfection, HBsAg and HBeAg were determined by using ELISA. Levels of HBV core-associated DNA and RNA were detected by using Southern and Northern blot, respectively. RESULTS: The inhibitory effects of PAP-S on HBsAg, HBeAg and HBV DNA were gradually enhanced with the increase of PAP concentration. When the concentration of PAP-S was 10 mug/mL, the inhibition rates of HBsAg, HBeAg and HBV DNA were 20.9%, 30.2% and 50%, respectively. After transfection of 1.0 mug and 2.0 mug plasmid pXF3H-PAP, the levels of HBV nucleocapside-associated DNA were reduced by 38.0% and 74.0% respectively, the levels of HBsAg in the media by 76.8% and 99.7% respectively, and the levels of HBeAg by 72.7% and 99.3% respectively as compared with controls. Transfection with 2 mug plasmid pXF3H-PAP reduced the levels of HBV nucleocapside-associated RNA by 69.0%. CONCLUSION: Both PAP-S and PAP encoded by a eukaryotic expression plasmid could effectively inhibit HBV replication and antigen expression in vitro, and the inhibitory effects were dose-dependent.
机译:目的:探讨商陆抗病毒蛋白种子(PAP-S)和真核表达质粒编码的PAP对乙型肝炎病毒(HBV)体外复制的抑制作用。方法:用不同浓度的PAP-S处理HepG2 2.2.15细胞。 ELISA法和荧光定量PCR法分别测定上清液中的HBsAg,HBeAg和HBV DNA。使用MTT法测定细胞毒性。将HepG2与真核表达质粒编码的各种PAP共转染,并复制能胜任野生型HBV 1.3倍的超长质粒。转染后第3天,通过ELISA测定HBsAg和HBeAg。分别通过Southern和Northern印迹检测HBV核心相关DNA和RNA的水平。结果:随着PAP浓度的升高,PAP-S对HBsAg,HBeAg和HBV DNA的抑制作用逐渐增强。当PAP-S浓度为10马克杯/毫升时,HBsAg,HBeAg和HBV DNA的抑制率分别为20.9%,30.2%和50%。转染1.0杯和2.0杯质粒pXF3H-PAP后,HBV核苷相关DNA水平分别降低了38.0%和74.0%,培养基中HBsAg水平分别降低了76.8%和99.7%,以及与对照相比,HBeAg分别升高了72.7%和99.3%。用2个马克杯质粒p​​XF3H-PAP转染可使HBV核苷相关RNA含量降低69.0%。结论:真核表达质粒编码的PAP-S和PAP均可有效抑制HBV的复制和体外抗原表达,且抑制作用呈剂量依赖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号